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BACTEC 460 and Solid Media for Recovery of 
Mycobacteria from Nonrespiratory Specimens 
S. Rusch-Gerdes, M. Pfohl. Not. Reference Centrefor Mycobacteria, 
Bontel, Gemrany 
E Favari, E Brunello, I. Piacentini. Microbiology, Immunology and 
Mrology Dept., Ospedale Ciuile Maggiore, Wrona, Italy 
Objective: The MB/BacT is a fuly automated, rapid, non-radio- 
metric system for the detection of Mycobacteria fiom c h c a l  sam- 
Objectives: Evaluation of the BACTEC 9000 h4B for the detection 
of mycobacteria from nonrespiratory specimens. 
Methods: Myco/F medium is designed for the primary isolation 
of mycobacteria using the BACTEC 9000 MB. The media uses 
a fluorescence-based oxygen sensor that detects the 0 2  decrease as 
bacteria consume oxygen. 579 specimens (gastric lavage: 123; pleural 
fluid 75; urine: 118; CSF 91; tissue: 80; stool 80; ascites 6; bone 
marrow: 2; blood 4) have been investigated by BACTEC 9000 MB 
and compared to the data assessed by BACTEC 460 and solid media. 
Results: A total of 45 strains (M. tuberculosis Complex: 28; 
MOTT 17) were detected. BACTEC 9000 MB plus solid media 
recovered 39 of the isolates and BACTEC 460 plus solid media 42, 
respectively. The mean time to detection of M .  tubenulosic Complex 
for smear negative specimens was 17.8 days with BACTEC 9000 
MB, 16.7 days with BACTEC 460 and 32.5 days with solid media. 
Smear positive specimens needed 12.6, 6.4 and 28.9 days with the 3 
methods, respectively. 
Conclusion: This study indicates that BACTEC 9000 MB may 
be used for detection of mycobacteria in laboratories desiring an 
automated, non radioactive method. 
ples. We are presently evaluating the MBBacT system in compari- 
son with egg me& (LJ), our routine isolation media. 
Method: A total of 312 c h i d  samples (222 non-blood and 90 
blood) have been tested with both methods sofar. Incubation time 
were 9 weeks for MB/BacT and 12 weeks for the egg media. Res- 
piratory samples were decontaminated using NALC-NaOH proce- 
dure. Blood samples were premated with Isolator (Wampole) and a 
total of 1 ml pellet (10 ml blood) was inoculated in the MB/BacT 
bottle supplemented with growth factors. 
Results: To date there have been 74 positive samples isolated on 
MB/BacT and 66 (89%) on LJ.40 positives were recovered fiom 
non-blood samples and 34 from blood samples. All positives from 
blood samples were identdied as MAC with a mean time to detection 
of 13.3 days (MB/BacT) and 27 days (LJ). Isolates from non-blood 
samples were identdied as M. tubercolosis (34), M .  gordonae (6). Mean 
time to detection for M .  tubercolosis was 13.8 days (MEVBacT) and 
35.2 days (LJ) and for M .  gordonae was 4.9 days (MB/BacT) and 15.6 
days (LJ). Contamination rates were 3% (MB/BacT) and 3.5% (LJ). 
Conclusion: The MB/BacT system is a rapid and sensitive 
method to detect mycobacteria in non-blood as well as blood speci- 
men. 
lp686/ Recovery and Detection of Mycobacteria in the 
MB/BacT Process Bottle from Seeded Blood 
Specimens Processed by Isolator Lysis 
Lp6841 comparison of the MB/BacT and the BACTEC 
460 for the isolation of Mycobacteria from 
Clinical Specimens 
€? Rohner, B. Ninet, C. Meual, R .  Auckenthaler. Barteriology 
Lboratoy, University Hospital Geneva, Switzerland 
The MB/BacT automated system is designed for the isolation of my- 
cobacteria from clinical specimens. It utilizes a colorimetric sensor 
and reflected light to continuously monitor the C 0 2  concentra- 
tion in the culture medium. We cornpared its performance to the 
BACTEC 12 B media for the radiometric BACTEC 460 insau- 
ment. In this ongoing study, 493 of the 1023 culture inoculated in 
equal parts into the vials of the 2 instruments after 4% NaOH de- 
contamination, could be evaluated after 8 weeks of incubation. The 
following specimen types were cultured: 294 respiratory, 37 cere- 
brospinal fluids, 94 other body fluids, 42 urines and 26 soft tissue 
samples. 
Overall 39 (7.9%) cultures yielded Mycobacteria, of these 35 were 
M. tuberculosis. With the MB/BacT system, 36 mycobacteria could 
be recovered, and 37 with the BACTEC 460 of which 34 were 
isolated form vials of both systems. When both systems were pos- 
itive, the BACTEC 460 always detected mycobacterial growth >2  
days earlier with only 2 exceptions. The BACTEC cultures with 
a growth index >10 (median = 200) were positive on the average 
11.6 (f5.4) days after vial inoculation, and the MB/BacT after 14.9 
(3~5.7) days. Microorganisms other than mycobacteria grew in 55 
(11.2%) MB/BacT cultures and 12 (2.4%) BACTEC cultures. 
The MB/BacT is a well automated system to detect M. tubenu- 
T.E. Zirkle. Organon Teknika Corporation, Durham, NC, USA 
Objectives: The purpose of h s  study is to evaluate the perfor- 
mance of the MB/BacT Process Bottle for use in blood culture 
procedures for mycobacteria. 
Method The MB/BacT System is a f d y  automated, non-inva- 
sive, non-radioactive system designed for the recovery and detection 
of mycobacteria in patient cultures other than blood. Of primary 
concern is the M .  avium complex (MAC) and M .  kansasii, commonly 
isolated from patients with AIDS and cancer. Other Mycobnrterium sp. 
were also tested. Blood &om healthy individuals was collected into 
Isolator Tubes, (Wampole Laboratories, Cranbury, NJ), seeded with 
approximately lo5 and lo3 CFU/ml and processed following manu- 
facturers directions. One-halfml of the sediment was inoculated into 
the MB/BacT process bottle with MB/BacT Reconstitution Fluid 
and incubated in the MB/BacT cabinet at 36°C. 
Results: Average times to detection for MAC were 7.7 days at 
lo5 CFU/ml and 11.7 days at lo3 CPU/ml; M .  kancasii s t r a i n s  were 
detected in 7.1 days (lo5 CFU/ml) and 10.5 days (lo3 CFU/ml). 
Detection times for M .  tuberculosis ranged fiom 8.5 to 21.7 days (lo5 
CFU/ml) and from 13.2 to 37.8 days (lo3 CFU/ml). Average times 
to detection for the other slow-growing organisms averaged 8.6 days 
at lo5 CFU/ml and 13.4 days at lo3 CFU/ml. Rapidly growing 
mycobacteria were detected in less than 3.0 days at both inoculum . .  leveb. 
Conclusions: The MB/BacT Process Bottle, used in conjunction 
with the Isolator Tube, has been shown to be a reliable method for 
detection of mycobacteria in these seeded blood specimens. 
h i s  in clinical specimens, without applying radioactive substrates. 
Further trials are required to determine whether mycobacteria other 
than tuberculosis grow equally well in t h i s  system. 
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I P687 I Evaluation of the BACTEC MGIT 960 Automated 
System for the Growth and Detection of 
Mycobacteria from Processed Sputum 
Specimens 
M. Warns, €? Hagemenn, PS. Beaty. Becton Dickinson MicrobioloBy 
Systems, Sparkc MDt USA 
The effectiveness of the non-radiomemc BACTEC Mycobacteria 
Growth Indicator Tube (MGIT) 960 automated Mycobacterial De- 
tection System was determined. Multiple strains of Mycobacterium 
tuberculosis, M .  m'um and M .  intracellulare were included in the study. 
Pooled sputa was processed using the NALC/NaOH decontami- 
nation procedure. MGIT supplemented with MGIT OADC and 
MGIT PANTA were inoculated with 0.5 mL of processed specimen 
and the vials were then seeded with mycobacteria. The test included 
multiple inoculum levels targeting approximately 10 CFU to 100 
CFU. The BACTEC46OTB system using BACTEC 12B medium 
was used as a control system. The recovery and time to detection 
(?TD) of mycobacteria in the MGIT 960 system was equivalent 
to the BACTEC 460TB system. The average time to detection for 
eight strains of M .  tuberculosis at multiple inoculum levels was 15.5 
days in the BACTEC MGIT 960 instrument. The average time to 
detection in the 12B conhul vials was 14 days. The average time 
to detection of M .  m'um/intracellulare was 9 days compared to 15.6 
days in the BACTEC 460TB system. Approximately lo4 CFU were 
present at positivity in the MGIT tube (AFB positive). Automated 
antimicrobial susceptibility testing on M. tuberculosis was also per- 
formed. Susceptibility and resistance of multiple s t r a i n s  of M .  W -  
bemlosis was demonstrated (Method of Proportion was used as a 
control). 
lp6881 Growth of Mycobactenurn paratuberculosis in 
the BBL@ MGIT" Mycobacteria Growth Indicator 
Tube 
D.T. Stitt, K.M. Sturm. Becton Dirkinson Microbiology Systems, Spark, 
MD,  USA 
Objectives: Evaluate modified MGIT tubes for the growth of My- 
tobacterium paratuberculosis (Mpt); compare to Herrold's Egg Yolk 
medium. 
Methods: Mpt is almost identical to M. avium, but has completely 
Merent growth requirements and characteristics. Mpt will not grow 
on media used to isolate mycobacteria unless it has been supple- 
mented with Mycobactin J. Mpt grows very slowly, specimens from 
goats can take up to 6 months to grow on solid media. Three strains 
of Mpt, two ATCC strains and one isolated from a pygmy goat, were 
grown in MGIT tubes with Mycobactin J, egg yok suspension, and 
pyruvate. Tubes were incubated at 37°C and read daily using a 365 
nm transilhminator. The time to detection of growth in MGIT 
tubes was compared to time to detection of growth on Herrold's 
Egg Yolk medium. The ability of the tubes to support growth in the 
presence of cetylpyridinium chloride (HPC), a specimen processing 
and decontamination chemical, was also tested. 
Results: Tubes inoculated with 5 x lo5 CFUs took 10-15 days 
to become positive. Growth on the Herrold's Egg Yolk medium 
was not detected until 4 weeks after inoculation. Tubes inoculated 
with 5 x lo4 CFUs took 13-20 days to become positive and was 
not detected on Herrold's medium until 5 weeks after inoculation. 
HPC in the presence of egg yolk emulsion did not inhibit growth in 
MGIT tubes. 
Condusions: Mpt can be gmwn in MGIT tubes with modified 
broth. The growth can be detected more rapidly than on solid me&. 
I P689 I The Detection of Mycobacteria in Blood Cultures 
Using the Bactec System: 6 Weeks versus 12 
We& Incubation? Routine Terminal 
Ziehl-Neelsen? 
G. Greub, K. Jaton, V Beer, J. Bille. Laboratory ofclinical 
Microbioloa, CNUI: Lausanne, Sw'tzehnd 
Rationale: Around 25% Cat HIV infected patients (pa) present 
disseminated mycobacteriosis mainly due to MAC and in a lesser 
extent to M .  genavensae. The latter one grows poorly and produces 
few amount of COZ. In addition, an absence of correlation between 
the number of bacilli and the G.I. has been reported. Therefore, 
a systematic Ziehl-Neelsen (ZN) examination could improve the 
detection of M. genavensae in blood cultures (BC) with a G.I. under 
the cut-off value (w). Moreover, a 6 w incubation period could be 
insufficient to detect MOTT h m  BC. 
Methods: in this prospective study, al l  BC submitted for my- 
cobacteria (taken m d y  from pts) were incubated for 12 w. ZN was 
used to confirm the presence of acid-fast bacteria in BC with a G.I. 
> 10. After 12 w of incubation, most (545/673) BC with a G.I. 
< 10 were examined by ZN. Impact of the BC remit was assessed 
remspectively for every pt with a positive Bactec BC after 2 6  w. 
Resultx 750 BC for mycobacteria from 378 pts were sent be- 
tween January 1st 1994 and August 15th 1995. Results are shown 
on the following table: 
~~~ ~ ~ 
CulNE Number ofBC (%) Number of pu (%) 
Positive§ 
within 6 weeks 
at 12 weeks 
Contaminated 
Negative' 
ZN ne@tive 
ZN positive 
ZN not done 
SG.1. > 10 & culture positive for Mycobmeria, "G.I. c 10 within 12 weeks; 'Ncgovc 
BC (G.I. < lo), where AFB were seen and further idenafred I M. gmmmrae by PRA. 
Overall, MAC was the most frequently recovered mycobacteria 
(74%) followed by M .  genauenrae (14.5%) andM. tuberculosis (7%). 
96% (45/47) of MAC were detected within 6 w, but only 37% (3/8) 
of M. genauensae (p = 0.0003). For 6L of 39 pts with positive BC, 
the delay to positivity was >6 w (1 MTbc, 3 M. genavenrae, 2 MAC; 
2/6 with clinical impact). For one additional pt*, only the routine 
ZN of the negative BC gave the dugnosis of M .  genavenrae. 
Conclusion: Neither a prolonged incubation longer than 6 w nor 
a routine ZN of the negative BC at 12 w seem to be cost-effective 
in mycobacterial BC. 
I P690 I Usefulness of a Solid and Liquid Medium 
Combination for Detection of Mycobacteria in 
Clinical Specimens 
M. de Montclos, M.E Remillieu, J.€? Flandmis. Lab. de 
Bacthiologie, C.H. Lyon-Sud, Pierre Bknite, France 
Objectives: To analyse the performance of a solid and liquid 
medium combination for the recovery of mycobacteria in an hospital 
laboratory receiving 300 clinical samples by week. 
Methods: Over a 8 month period (jan-aug 1996), 10,674 dtnical 
samples were treated by NALC-NaOH method and aliquots of 0.2 
ml were inoculated onto MGIT (Becton Dickinson) and Coletsos 
(Sanofi-Diagnostics Pasteur) media. Cultures were incubated at 37OC 
and regularly observed for 90 days. 
Results: Mycobacteria were isolated from 230 specimens. 74.8% 
of mycobacteria were recovered with MGIT medium, 58.7% with 
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Coletsos medium. 
Dlstribunon of porinve culture accordmg to the medm 
~~ 
both meda + Col + MGIT- Col - MGIT+ 
M. tubmubrir (n = 135) 64 27 
M. ovium (n = 29) 8 1 
M .  godome (n = 48) 3 20 
Others (n = 18) 2 10 
Total (n = 230) 77 58 
44 
20 
25 
6 
95 
50.6% of mycobacteria were isolated before 30 days of incubation 
with MGIT, 47.4% with Coletsos medium. 
Conclusions: MGIT medium was more sensitive than Coletsos 
medium but the combination with a solid medium seems very useful 
to optimize the recovery of mycobacteria. Difference in time for 
growth detection was weak for M. tubernrlosis but more important 
for M. avium. 
Ip6911 Utilii of Adenosine Deaminase Activity in 
E. Vidal l ,  MJ. Cuesta ', E. Nuiio ', I. Suarez ', J.L. Sampedro ', 
R. Luque6, M. Gonzalez7, J. Miram6n8, L. Rodriguez', 
S. Gonzalez lo, A. Corrales ", F! Martin 12, J. Marin 13, A. Villar 14, 
J. Galvarro j5  for the Community Hospitals of Andalusia (Spain). 
Cabra, Spain, 'Jerez, Spain, Velez-Mhlaga, Spain, 4Huelva, Spain, 
'Linares, Spain, 6Mofril, Spain, 7La Linea, Spain, 'Ronda, Spain, 
g ~ ~ z ~ b ~ ~ ~ ,  Spain, "Algen'ras, Spain, "Baza,  Spain, "Marbella, 
Spain, '30suna, Spain, I 4  Ubeda, Spain, '5Riofinto, Spain 
The adenosine deaminase activity (ADA) in CSF was found usell to 
separate tuberculous meningitis (TM) of the other aseptic meningitis 
(AM). 
Objective: To evaluate the utility of ADA in differential diagnosis 
of AM. 
Setting: 15 community-based hospitals without neurologie de- 
partment h m  Andalusia. 
Methods: we studied 103 adults (77 men and 26 women) with 
meningitis of different etiologies: 18 pyogenic meningitis (PM), 25 
TM, 7 criptococcous meningitis (CM), 38 lymphocitic meningitis 
(LM) and 15 indeterminate meningitis (MI) [defined by neutrophilic 
pleocytosis and normal glucosa in CSF]. 25 patients were HIV (15 
TM, 8 CM, 2 LM, 1 MI). 
Results: The mean ADA level, range and sigdcance of compar- 
ison between TM ADA mean and other meningitis (P) are shown in 
TABLE 1. For a cutoff point of 512 UI/l, ADA level has: 1) a sensi- 
tivity of 84% and a specificity of 89.5%; 2) a positive predictive value 
(PPV) of 87.5% and a negative predictive value ("V) of 89.7% as 
criterion of TM vs LM; and 3) a PPV of 91.3% and a NPV of 76.4% 
for TM vs MI. 
Aseptic Meningitis 
No mean nnw P 
PM 18 10.67 1-50 0.009 
TM 25 23.28 2-73 
CM 7 15.57 2-50 0.1442 
LM 38 5.10 1-23 O.oOo0 
IM 15 9.07 1-58 0.0004 
Conclusion: ADA level 212 UI/l was a useful test for to disM- 
guish TM h m  the other AM, but a low ADA level not exclude the 
TM diagnostic. 
New Betalactams 
In vitm Activity of Cefepime against 
Multiresistant Nosocomial Gram-negative 
Bacteria 
J. Blahovi, V KrZmCry, K. Kr;ilikovi. Imt. ofReventive and Clin. 
Med., Bratislava, Slovakia 
Objectives: Cefepime @MY 28142, Bristol-Meyea Squibb) is 
classified as the "fourth generation" cephalosporin. We tested the 
in vitro activity of cefepime against 89 cefotaxime- and cef- 
tazidime-resistant isolates of "problematic" bacteria (Stenofrophomonas 
maltophilia, Flavobacterium meningosepfinrm, Mebsiella pneumoniae, Sph- 
ingobacterium mulfivomm, Pseudomonas amginosa, Enterobacter c l o u e ,  
Acinefobacter baumanii, Burkholdm'a cepan'a). Bacterial strains used in 
this study were dinical isolates from various hospitals. Strains were 
resistant to 25 pg/ml and more of ceftazidune. 
Methods: MIC(s) were determined by an agar dilution method 
with 2-fold dtlutions of antibiotics. To visualise the presence of ESBL 
in strains,  double-disk Husion test was used. Transfer of antibiotic 
resistance in liquid cultures was performed as described by Knothe 
et al. (1983). 
Results: From 30 S. maltophilia, E meningosepficum and Sph. mul- 
tivonrm s t r a i n s  naturally resistant to imipenem, 26 were susceptible 
to cefepime with MIC in range 3.13-6.25 ,ug/ml. Four S. mal- 
tophilia and 2 of 22 I? aemginosa strains had MIC = 12.5 p g / d  and 
were considered resistant. Transferable resistance to cefotaxime and 
ceftazidune and double-disk a s i o n  test demonstrated the pres- 
ence of ESBL in the majority of K. pneumoniae, E .  cloacae and A. 
baumanii strains tested. MIC(s) of these strains were 1.56-6.25 of 
p g / d  of cefepime, i.e. cefepime is less a€fected by plasmid-mediated 
p-lactamases than ceftazidime and cefotaxime. 
Conclusions: Cefepime showed higher activity than ceftazidime 
with MIC in range 3.13-12.5 pg/ml in all strains tested. 
Comparative Activii of Cefepime Against 
Respiratory Pathogens of I? aemginosa A. 
baumanii, and Enterics from ICU Patients 
K.E. Aldridge', D. Ashcrafl', M. Gelfand'. 'LSUMedical  C e n f q  
New Orleans, LA, U S A ,  'Mefhodist Hospital, Memphis, TN U S A  
Continuing increased rates of resistance to broad-spectrum p-lactams 
is predominantly due to extended spectrum p-lactamases. Ce- 
fepime, a new fourth generation alpha-methoximino aminothiazolyl 
cephalosporin, has been shown to be stable to many ESBLS and 
because it is a zwitterion may penetrate most bacterial isolates to a 
greater degree. 
Objectives: To compare the in vim activity of cefepime to that 
of other antimicroblals against I? aeruginosa, A.  baumanii, and En- 
terobacteriaceae strains isolated h m  respiratory pathogens h m  ICU 
patients. 
Methods: Each isolate was tested to the various antimicrobials us- 
ing an NCCLS broth microdilution method. A total of 122 nondu- 
plicate strains were tested. 
Results: Agdlnst enteric isolates (all B-lactamase producers) ce- 
fepime was the most active antimicrobial tested with a mode MIC 
and MI& of 0.03 pg/ml and MIC" of 0.25 pg/ml. By com- 
parison cefepime was 4-fold more active than ofloxacin, gentarr- 
icin, and TMP/SMZ; 16- to 128-fold more active than cefeiaxone, 
ceftazidime, and imipenem; and 64- to 512-fold more active than 
B-lactamase inhibitor combinations. Against I? amginosa cefepime 
had comparable activity to ceftazidime, was 4-fold more active than 
imipenem and ampi&/sulbactam, and 8- to 16-fold more ac- 
tive than cefiriaxone and ticarcillin/clavulanate. Agamst A. baumanii 
